To boost research for approval of new corona treatment drug “Avigan” Government 5/06 March 30
As the spread of the new coronavirus spreads worldwide, the government has decided to go through formal clinical trials and seek formal approval of the new influenza coronavirus as a new coronavirus drug after a trial process. The policy is to support research toward drug development.
At present, there is no silver bullet for the new coronavirus, which is spreading worldwide, and Prime Minister Abe said at a news conference that `` the development of effective therapeutic drugs and vaccines will help reduce anxiety as soon as possible. We will bring together our wisdom and accelerate it. "
The new coronavirus is being tested for efficacy and safety in Japan and abroad for the possibility that another therapeutic agent for infectious diseases may be used. The government has decided to go through a clinical trial process for the influenza drug Avigan to seek formal approval of the new coronavirus.
It is said that the therapeutic effect of Avigan has been recognized in China, and clinical research has begun in Japan, such as at Fujita Medical University Hospital in Aichi Prefecture, and the government will expand clinical research in cooperation with the desired country in the future. We will also start increasing drug production.
In addition, the treatment of pancreatitis drug Fusan is scheduled to begin with the consent of patients in advance as a clinical study, and the government will support research for the development of effective therapeutics. You.